Migraine sufferers have new hope for relief on the horizon, thanks to the first-ever FDA approved electronic headband device marketed to prevent migraine headaches. The U.S. Food and Drug Administration (FDA) has approved Cefaly, which is an electronic headband that looks somewhat otherworldly. This device is intended as an alternative treatment to replace migraine drugs.
Migraines can result from a variety of trigger stimuli, such as bright or strobing light, heat, loud noise, and cause an intense pounding or vibrating sensations in the head of sufferers. They often trigger other bodily responses, such as nausea, vomiting, and an aversion to light and sound. The attacks can vary greatly in intensity and cause pain from hours to days. Moreover, the headaches can be so severe that it affects a person’s ability to function. Furthermore, migraines are three times more common in women than men.
The electronic headband device is small, portable, and battery-powered and it will be worn similar to a headband. After the device is properly positioned on the forehead, it releases an electric current to the skin and body tissue to stimulate the trigeminal nerve, which is the nerve associated with migraines. The device has a prevention program designed to boost the production of endorphins that blocks pain and provides relief during attacks. Additionally, it should bring immediate relief to migraine sufferers and can be used as a preventive measure before onset of migraine pain. Moreover, the device will require a prescription from a medical doctor. The FDA has recommended daily usage for the device not exceed 20 minutes to reap the preventative benefits.
Migraine relief is now on the market for the estimated 12 percent of the United States population that suffers from the debilitating disorder, thanks to the FDA approved electronic headband. The device was created in part to help sufferers who cannot tolerate the current migraine medications available, as well as those individuals who prefer a more organic approach to treatment. The additional benefits sufferers could reap from the reduced ingestion of pain medications might be immeasurable. Moreover, migraine studies have shown that the condition could potentially lead to brain damage.
The device will be available with a prescription to users over age 18 and it is manufactured by a Belgium-based company. Additionally, this device can also be used by children over eight years old. Children below eight years of age could use Cefaly under adult supervision. Moreover, it is an ideal alternative for pregnant women and nursing mothers to use, as opposed to ingesting potentially dangerous pain killing medication.
The announcement of FDA approval for Cefaly has created great excitement among the medical community. Many experts contend the advent of having a migraine preventing device out in the market is revolutionary for not only migraine sufferers but the ever-expanding field of pain management as a whole.
Thanks to the FDA approved electronic headband, migraine relief is now on the market for sufferers who cannot tolerate pain medications or might have other health issues that prohibit them from taking medications to ease their pain. Medical providers and patients alike could benefit tremendously now that there is a migraine preventing device out in the market. A device that can not only treat migraines but has been designed to prevent them if applied in time. The potential benefits of such a device could prove priceless.
By Leigh Haugh
Other Articles by This Author: